Patents Assigned to Audion Therapeutics
  • Notch pathway signaling inhibitor compounds
    Patent number: 10450317
    Abstract: The present invention provides the following compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing said compounds useful as a Notch pathway signaling inhibitor for the treatment of named cancers, sensorineural hearing loss caused by auditory hair cell loss, and inducing auditory hair cell generation.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: October 22, 2019
    Assignees: Eli Lilly and Company, Audion Therapeutics
    Inventors: Julia Marie Clay, Albert Edge, Philip Arthur Hipskind, John C. Gill, Bharvin Kumar Patel, Helmuth Hendrikus Gerardus Van Es, Aaron D. Wrobleski, Gaiying Zhao